Cyclobenzaprine Hydrochloride
NDC 72789-046, cyclobenzaprine hydrochloride, tablet, film coated, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 72789-046
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077797
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72789-046 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72789-046-03 | 72789004603 | 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-03) |
| 72789-046-04 | 72789004604 | 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-04) |
| 72789-046-06 | 72789004606 | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-06) |
| 72789-046-10 | 72789004610 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-10) |
| 72789-046-12 | 72789004612 | 12 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-12) |
| 72789-046-14 | 72789004614 | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-14) |
| 72789-046-20 | 72789004620 | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-20) |
| 72789-046-30 | 72789004630 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-30) |
| 72789-046-40 | 72789004640 | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-40) |
| 72789-046-60 | 72789004660 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7829a96a-3668-4d88-90e9-0ecbedb2bd7e
Use it
Look up 72789-046 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72789-046 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72789-046. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.